📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer (2018)

First Author: Chou A

Attributed to: Glasgow Molecular Pathology (GMP) Node funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/gutjnl-2017-315144

PubMed Identifier: 29080858

Publication URI: http://europepmc.org/abstract/MED/29080858

Type: Journal Article/Review

Parent Publication: Gut

Issue: 12

ISSN: 0017-5749